MGEN
Miragen Therapeutics Inc
Halal Rating :
Last Price
$18.14
Last updated:
Market Cap
-
7D Change
2.08%
1 Year Change
-9.3%
Company Overview
Exchange
Next Earnings Date
Miragen Therapeutics Inc was a clinical-stage biopharmaceutical company focused on developing microRNA-targeted therapies. However, the company has undergone significant changes. In January 2021, Miragen Therapeutics merged with Viridian Therapeutics and adopted the Viridian name, though initially keeping the MGEN ticker. Later in 2021, the company changed its ticker to VRDN.
Due to this corporate transformation, investors interested in this company should now follow Viridian Therapeutics (VRDN) instead of MGEN.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $86000.0 | $84.57m | - | $1.0m | 0.00% | 1.19% |
| June 30, 2024 | $72000.0 | $72.86m | - | $597000.0 | 0.00% | 0.82% |
Company Impact
Help us evaluate Miragen Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.